JYNWEL Foundation co-founder and director Jho Low is looking to improve cancer care and computing technology, as referenced in a Scientific American blog post on Monday.
The Malaysian born third generation entrepreneur and philanthropist, along with IBM Watson’s chief technology officer Rob High, showcased how the exciting work being done at MD Anderson Cancer Centre with IBM Watson can change healthcare worldwide.
At MD Anderson, IBM Watson is being used to drive the Oncology Expert Adviser, which acts as a live reference manual and a virtual expert adviser for clinicians, providing the best treatment options for cancer patients.
The technology can obtain patient information, compare it against similar cases, and their responses to treatment, analyse standard practices, and refer to clinical literature.
“We believe that Watson will ultimately bring high-quality, evidence-based medicine to patients around the world, regardless of financial or geographic limitations,” write Rob High and Jho Low in the Scientific American post.
“This democratisation of healthcare may prove to be Watson’s most lasting contribution.”
Jynwel Foundationwas founded as a third-generation family vehicle of the Low family, in honour of their grandfather and low-profile billionaire entrepreneur Low Meng Tak.
He passed away from Leukemia in 2013 in Malaysia, and the Low family has continued to fund aggressive cancer research in his honour through the charitable arm of investment firm Jynwel Capital.
Jynwel Foundation committed millions to MD Anderson’s Moon Shots Programme in 2013 to support the Oncology Expert Adviser tool that IBM Watson powers.
Jynwel Capital, co-founded by third generation Jho Low and Szen Low from the Low family, has recently shown interest together with Abu Dhabi Funds in buying Boston-based athletic company Reebok from Adidas, as mentioned in The Wall Street Journal article on Sunday.
The Wall Street Journal’s research has also indicated that the Low family has an estimated US$1.75 billion (RM5.70 billion) net-worth, mainly generated from Low Meng Tak from the 1940s through substantial mining and liquor businesses across China and Asia.
Read the Scientific American post here:http://blogs.scientificamerican.com/mind-guest-blog/2014/10/20/expert-cancer-care-may-soon-be-everywhere-thanks-to-watson/